4
Changes in Ownership
Jade Biosciences, Inc. Filed Acc 0001415889-24-013630
CHIEF MEDICAL OFFICER sold 4,000 shares at an average $21.08 ($84,332)
- CHIEF MEDICAL OFFICER acquired 4,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gillies Hunter · CHIEF MEDICAL OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,000 | $2.14 | $8,560 | 9,602 | D |
| 2024-05-17 | Sale : show line 2 in the form 10b5-1 | −3,914 | $21.07 | $82,452 | 5,688 | D |
| 2024-05-17 | Sale : show line 3 in the form 10b5-1 | −86 | $21.86 | $1,880 | 5,602 | D |
| Open-market sales · 4,000 sh · avg $21.08 · $84,332 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-17 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −4,000 | 11,324 | D |
Loading xslF345X05/form4-05172024_070505.xml…